Indaptus Therapeutics INDP
NASDAQ INDP
$2.99 +0.03 (+1.01%)
As of: Oct 21, 2026 · 10:27 AM EDT

Indaptus Therapeutics (INDP) Convertible Debt (2025)

Updated

Indaptus Therapeutics (INDP) posted Convertible Debt of $5.7 million for Q2 2025.

Analysis

Indaptus Therapeutics (INDP) Convertible Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.34 Bn 1,100.93 Bn 19.71 Bn
2 Johnson & Johnson 615.91 Bn 534.44 Bn 17.26 Bn
3 AbbVie 505.47 Bn 478.59 Bn 12.70 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn
5 Novartis Ag 298.18 Bn 262.17 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 236.22 Bn 191.62 Bn 7.24 Bn
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn
9 Pfizer 170.14 Bn 116.79 Bn 10.94 Bn
10 Indaptus Therapeutics 190.41 Mn 163.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 5.70 Mn
API Access

Indaptus Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=INDP&period=max&api_key=YOUR_API_KEY